marie-claude marchand

TVM Capital Life Science is a group of advisories and fund managers for Venture Capital funds, investing into biotech, pharmaceutical, diagnostic and medtech companies.

* Executive commercial strategist * Consulting firm offering its services to top level management seeking support for their emerging market development and/or business model transformation. * Services offered * commercial strategy management: business model evaluation and transformation * diagnostic: market and processes analysis, organizational structuring * complete commercial plan centered on the customer: omni-channel marketing * sales deployment, planning, hiring, forecasting and measurability matrix * Industries served up to now: pharma & biotech, technology, non-profit & NGO, law, energy, freight logistics technology, engineering, public health organizations, manufacturing. * References on demand and aligned with project's nature

* Sales & Marketing leadership (NA, EU and Asia) * meet successfully and with sustainability sales objectives, US$500M, while maximizing YOY growth * augment regional profitability, >14% savings by re-aligning 3 commercial operations * design of a multi-channel marketing strategy with regional analysis and targeted sales deployment * launch numerous and successful new products worldwide, brand expansion * tailor sales tools to regional specificities, >500 products

* manage Global Key Accounts team and its international cross-functional business group * introduce performance enhancement strategies and processes for geographically dispersed teams which led to >14% growth * inception of one of the first Personalized Medicine team in the industry including its geographic expansion * development of technological road-map for targeted market segments and acquisition of new technologies: delivered, with a multi-disciplinary team, two FDA (Food and Drug Administration USA) approved companion diagnostics: colorectal and lung cancer * promotion of customer centric strategy and innovative custom processes: repackaging, co-branding, OEMs, tailored assays, etc. * negotiation of agreements and management of multi-party and international projects * multiple valuation, due diligence and post-merger integration programs

Until its purchase by QIAGEN (see above) in July 2005, Nextal was a start-up company with 36 employees financed by venture capitals. It offered consumables designed for protein crystallization, a highly specialized market, to university government, biotech and pharmaceutical research labs. Within 2 years of product development, the company was selling more than 15 product lines to 500 customers in 18 countries, all of which were developed and produced internally. Rapid growth, patented products and a prominent market position led to the acquisition of Nextal by QIAGEN. Biotech Industry achievements business case building, product development, financing, logistics, patent processing and complementary products idea commercial strategy: company brand, market presence in 18 countries, logistics and set up of technical, customer service and distribution networks

Innovative diagnostic through the eyes Optina's mission is to positively impact the life of Millions of people around the world by setting the reference in asymptomatic and early diseases screening. 1st indication in Alzheimer Disease